LIFESTANCE HEALTH GROUP INC (LFST) Fundamental Analysis & Valuation

NASDAQ:LFST • US53228F1012

Current stock price

6.33 USD
0 (0%)
At close:
6.33 USD
0 (0%)
After Hours:

This LFST fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LFST Profitability Analysis

1.1 Basic Checks

  • In the past year LFST was profitable.
  • LFST had a positive operating cash flow in the past year.
  • LFST had negative earnings in 4 of the past 5 years.
  • LFST had a positive operating cash flow in 4 of the past 5 years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • LFST has a Return On Assets of 0.44%. This is comparable to the rest of the industry: LFST outperforms 50.49% of its industry peers.
  • LFST has a Return On Equity of 0.64%. This is comparable to the rest of the industry: LFST outperforms 54.46% of its industry peers.
  • LFST's Return On Invested Capital of 0.97% is on the low side compared to the rest of the industry. LFST is outperformed by 62.38% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROIC 0.97%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • With a Profit Margin value of 0.68%, LFST perfoms like the industry average, outperforming 52.48% of the companies in the same industry.
  • LFST has a Operating Margin of 1.70%. This is comparable to the rest of the industry: LFST outperforms 46.53% of its industry peers.
  • LFST's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.7%
PM (TTM) 0.68%
GM N/A
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LFST Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFST is destroying value.
  • LFST has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LFST has more shares outstanding
  • LFST has a better debt/assets ratio than last year.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.43 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LFST has a Altman-Z score of 2.43. This is comparable to the rest of the industry: LFST outperforms 56.44% of its industry peers.
  • LFST has a debt to FCF ratio of 2.55. This is a good value and a sign of high solvency as LFST would need 2.55 years to pay back of all of its debts.
  • LFST has a Debt to FCF ratio of 2.55. This is in the better half of the industry: LFST outperforms 75.25% of its industry peers.
  • LFST has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • LFST's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. LFST outperforms 72.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Altman-Z 2.43
ROIC/WACC0.11
WACC8.51%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • LFST has a Current Ratio of 1.65. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
  • LFST has a Current ratio of 1.65. This is in the better half of the industry: LFST outperforms 65.35% of its industry peers.
  • A Quick Ratio of 1.65 indicates that LFST should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.65, LFST is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. LFST Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 112.50% over the past year.
  • The Revenue has grown by 13.85% in the past year. This is quite good.
  • Measured over the past years, LFST shows a very strong growth in Revenue. The Revenue has been growing by 30.44% on average per year.
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%

3.2 Future

  • Based on estimates for the next years, LFST will show a very strong growth in Earnings Per Share. The EPS will grow by 134.65% on average per year.
  • The Revenue is expected to grow by 14.45% on average over the next years. This is quite good.
EPS Next Y189.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue Next Year15.26%
Revenue Next 2Y14.67%
Revenue Next 3Y14.45%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. LFST Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 316.50, which means the current valuation is very expensive for LFST.
  • Compared to the rest of the industry, the Price/Earnings ratio of LFST is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 25.71. LFST is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 109.51, LFST can be considered very expensive at the moment.
  • 61.39% of the companies in the same industry are cheaper than LFST, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.83. LFST is valued rather expensively when compared to this.
Industry RankSector Rank
PE 316.5
Fwd PE 109.51
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • LFST's Enterprise Value to EBITDA is on the same level as the industry average.
  • LFST's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 22.42
EV/EBITDA 31.67
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as LFST's earnings are expected to grow with 134.65% in the coming years.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y186.93%
EPS Next 3Y134.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LFST Dividend Analysis

5.1 Amount

  • LFST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LFST Fundamentals: All Metrics, Ratios and Statistics

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (3/13/2026, 8:00:02 PM)

After market: 6.33 0 (0%)

6.33

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners42.94%
Inst Owner Change5.79%
Ins Owners2.98%
Ins Owner Change1.41%
Market Cap2.47B
Revenue(TTM)1.42B
Net Income(TTM)9.66M
Analysts82.35
Price Target9.07 (43.29%)
Short Float %6.24%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)980.59%
Min EPS beat(2)100%
Max EPS beat(2)1861.18%
EPS beat(4)4
Avg EPS beat(4)532.13%
Min EPS beat(4)67.32%
Max EPS beat(4)1861.18%
EPS beat(8)8
Avg EPS beat(8)286.19%
EPS beat(12)9
Avg EPS beat(12)177.02%
EPS beat(16)11
Avg EPS beat(16)131.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.3%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.33%
Revenue beat(16)8
Avg Revenue beat(16)0.11%
PT rev (1m)1.27%
PT rev (3m)3.7%
EPS NQ rev (1m)100%
EPS NQ rev (3m)100%
EPS NY rev (1m)36%
EPS NY rev (3m)36%
Revenue NQ rev (1m)1.8%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 316.5
Fwd PE 109.51
P/S 1.73
P/FCF 22.42
P/OCF 16.88
P/B 1.62
P/tB 49.34
EV/EBITDA 31.67
EPS(TTM)0.02
EY0.32%
EPS(NY)0.06
Fwd EY0.91%
FCF(TTM)0.28
FCFY4.46%
OCF(TTM)0.37
OCFY5.92%
SpS3.65
BVpS3.9
TBVpS0.13
PEG (NY)1.67
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROCE 1.24%
ROIC 0.97%
ROICexc 1.11%
ROICexgc 8.12%
OM 1.7%
PM (TTM) 0.68%
GM N/A
FCFM 7.73%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-21.84%
ROICexc growth 3YN/A
ROICexc growth 5Y6.17%
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Debt/EBITDA 3.37
Cap/Depr 65.98%
Cap/Sales 2.54%
Interest Coverage 1.36
Cash Conversion 185.23%
Profit Quality 1138.63%
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 2.43
F-Score8
WACC8.51%
ROIC/WACC0.11
Cap/Depr(3y)48.92%
Cap/Depr(5y)87.16%
Cap/Sales(3y)2.7%
Cap/Sales(5y)6.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y189.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%
Revenue Next Year15.26%
Revenue Next 2Y14.67%
Revenue Next 3Y14.45%
Revenue Next 5YN/A
EBIT growth 1Y175.64%
EBIT growth 3YN/A
EBIT growth 5Y9.27%
EBIT Next Year1864.04%
EBIT Next 3Y208.48%
EBIT Next 5YN/A
FCF growth 1Y28.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.26%
OCF growth 3Y40.42%
OCF growth 5YN/A

LIFESTANCE HEALTH GROUP INC / LFST Fundamental Analysis FAQ

What is the fundamental rating for LFST stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFST.


What is the valuation status for LFST stock?

ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.


What is the profitability of LFST stock?

LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 2 / 10.


What is the valuation of LIFESTANCE HEALTH GROUP INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LIFESTANCE HEALTH GROUP INC (LFST) is 316.5 and the Price/Book (PB) ratio is 1.62.